{"address1": "4995 Murphy Canyon Road", "address2": "Suite 300", "city": "San Diego", "state": "CA", "zip": "92123", "country": "United States", "phone": "760 471 8536", "website": "https://www.conduitpharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Conduit Pharmaceuticals Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It has strategic services agreement with formulation development CDMO Agility Life Sciences to develop new solid oral-dosage form products. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.", "fullTimeEmployees": 6, "companyOfficers": [{"maxAge": 1, "name": "Dr. David Joszef Tapolczay", "age": 65, "title": "CEO & Director", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 558578, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Joanne M. Holland", "age": 49, "title": "Chief Scientific Officer", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.0092, "open": 0.0112, "dayLow": 0.0112, "dayHigh": 0.0136, "regularMarketPreviousClose": 0.0092, "regularMarketOpen": 0.0112, "regularMarketDayLow": 0.0112, "regularMarketDayHigh": 0.0136, "beta": 2.268, "volume": 20070, "regularMarketVolume": 20070, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "fiftyTwoWeekLow": 0.0112, "fiftyTwoWeekHigh": 0.0136, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "profitMargins": 0.0, "floatShares": 6508112, "bookValue": -4.905, "netIncomeToCommon": -17802000, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 0.0136, "recommendationKey": "none", "totalCash": 554000, "totalCashPerShare": 0.083, "ebitda": -14962000, "totalDebt": 7457000, "quickRatio": 0.052, "currentRatio": 0.253, "returnOnAssets": -1.68816, "freeCashflow": -5649125, "operatingCashflow": -9682000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "CDTTW", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "regularMarketTime": 1743537600, "exchange": "NCM", "messageBoardId": "finmb_1772079937", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "priceToBook": -0.002772681, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "marketState": "PRE", "hasPrePostMarketData": true, "regularMarketChange": 0.0044, "regularMarketDayRange": "0.0112 - 0.0136", "fullExchangeName": "NasdaqCM", "fiftyTwoWeekLowChange": 0.0024000006, "fiftyTwoWeekLowChangePercent": 0.21428578, "fiftyTwoWeekRange": "0.0112 - 0.0136", "fiftyTwoWeekHighChange": 0.0, "fiftyTwoWeekHighChangePercent": 0.0, "longName": "Conduit Pharmaceuticals Inc.", "regularMarketChangePercent": 47.826084, "regularMarketPrice": 0.0136, "displayName": "Conduit Pharmaceuticals", "trailingPegRatio": null}